BridgeBio Pharma Inc (BBIO)

Finanzdaten der BridgeBio Pharma Inc-Aktie (BBIO)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	57.35% 1.745	4.091	1.641	1.826	1.87
Cost Of Revenue	0.00% 0.598	0.598	0.599	0.651	-
Gross Profit	67.16% 1.147	3.493	1.042	1.175	-
Operating Expenses	10.78% 178.56	161.19	147.14	127.99	131.10
Interest Income/Expense	0.19% 20.27	20.31	20.59	20.12	19.99
Benefits Costs and Expenses	6.27% 172.07	183.58	162.34	144.56	142.44
Costs And Expenses	10.74% 179.16	161.78	147.74	127.99	131.10
Operating Income/Loss	12.51% -177.42	-157.69	-146.10	-126.16	-129.23
Nonoperating Income/Loss	132.52% 7.088	-21.80	-14.60	-16.57	-11.34
Income/Loss From Continuing Operations Before Tax	5.10% -170.33	-179.49	-160.70	-142.73	-140.57
Income/Loss From Continuing Operations After Tax	5.10% -170.33	-179.49	-160.70	-142.73	-140.57
Net Income/Loss	5.10% -170.33	-179.49	-160.70	-142.73	-140.57
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	12.41% -2.18	-2.489	-2.804	-2.576	-2.979
Basic Average Shares	97.61% 3.9004	163.31	160.54	152.65	0.6306
Diluted Average Shares	97.61% 3.9004	163.31	160.54	152.65	0.6306
Basic Earnings Per Share	11.11% -0.96	-1.08	-0.98	-0.92	-0.92
Diluted Earnings Per Share	11.11% -0.96	-1.08	-0.98	-0.92	-0.92
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-